Home > Research > Publications & Outputs > Gene delivery with organic electronic biomaterials

Research

Associated organisational unit

Electronic data

  • Clancy-Hardy-CPD-accepted

    Rights statement: © 2017 Bentham Science Publishers

    Accepted author manuscript, 2.19 MB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

Keywords

View graph of relations

Gene delivery with organic electronic biomaterials

Research output: Contribution to Journal/Magazine › Literature review › peer-review

Published

Standard

Gene delivery with organic electronic biomaterials. / Clancy, Kathryn; Hardy, John George.
In: Current Pharmaceutical Design, Vol. 23, No. 24, 09.2017, p. 3614-3625.

Research output: Contribution to Journal/Magazine › Literature review › peer-review

Harvard

Clancy, K & Hardy, JG 2017, 'Gene delivery with organic electronic biomaterials', Current Pharmaceutical Design, vol. 23, no. 24, pp. 3614-3625. https://doi.org/10.2174/1381612823666170710124137

APA

Clancy, K., & Hardy, J. G. (2017). Gene delivery with organic electronic biomaterials. Current Pharmaceutical Design, 23(24), 3614-3625. https://doi.org/10.2174/1381612823666170710124137

Vancouver

Clancy K, Hardy JG. Gene delivery with organic electronic biomaterials. Current Pharmaceutical Design. 2017 Sept;23(24):3614-3625. Epub 2017 Jul 19. doi: 10.2174/1381612823666170710124137

Author

Clancy, Kathryn ; Hardy, John George. / Gene delivery with organic electronic biomaterials. In: Current Pharmaceutical Design. 2017 ; Vol. 23, No. 24. pp. 3614-3625.

Bibtex

@article{dc0fca5e739843df9b9bda3a44ada13d,
title = "Gene delivery with organic electronic biomaterials",
abstract = "Gene therapy may be capable of treating a variety of diseases, a prerequisite of which is the successful delivery of polynucleic acids (e.g., DNA, RNA) to a patient{\textquoteright}s cells. Delivery can be achieved technologically (e.g., using electroporation), using viruses (natural gene delivery vectors) or non-viral vectors (e.g., lipids, nanoparticles, polymers). This article aims to give the reader an overview of the use of organic electronic materials (i.e., fullerenes, graphenes and conjugated polymers) as non-viral gene delivery vectors.",
keywords = "Organic electronics, carbon nanotubes, fullerene, graphene, conjugated polymer, gene delivery, gene therapy, biodegradable",
author = "Kathryn Clancy and Hardy, {John George}",
note = "{\textcopyright} 2017 Bentham Science Publishers",
year = "2017",
month = sep,
doi = "10.2174/1381612823666170710124137",
language = "English",
volume = "23",
pages = "3614--3625",
journal = "Current Pharmaceutical Design",
issn = "1873-4286",
publisher = "Bentham Science Publishers B.V.",
number = "24",

}

RIS

TY - JOUR

T1 - Gene delivery with organic electronic biomaterials

AU - Clancy, Kathryn

AU - Hardy, John George

N1 - © 2017 Bentham Science Publishers

PY - 2017/9

Y1 - 2017/9

N2 - Gene therapy may be capable of treating a variety of diseases, a prerequisite of which is the successful delivery of polynucleic acids (e.g., DNA, RNA) to a patient’s cells. Delivery can be achieved technologically (e.g., using electroporation), using viruses (natural gene delivery vectors) or non-viral vectors (e.g., lipids, nanoparticles, polymers). This article aims to give the reader an overview of the use of organic electronic materials (i.e., fullerenes, graphenes and conjugated polymers) as non-viral gene delivery vectors.

AB - Gene therapy may be capable of treating a variety of diseases, a prerequisite of which is the successful delivery of polynucleic acids (e.g., DNA, RNA) to a patient’s cells. Delivery can be achieved technologically (e.g., using electroporation), using viruses (natural gene delivery vectors) or non-viral vectors (e.g., lipids, nanoparticles, polymers). This article aims to give the reader an overview of the use of organic electronic materials (i.e., fullerenes, graphenes and conjugated polymers) as non-viral gene delivery vectors.

KW - Organic electronics

KW - carbon nanotubes

KW - fullerene

KW - graphene

KW - conjugated polymer

KW - gene delivery

KW - gene therapy

KW - biodegradable

U2 - 10.2174/1381612823666170710124137

DO - 10.2174/1381612823666170710124137

M3 - Literature review

VL - 23

SP - 3614

EP - 3625

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1873-4286

IS - 24

ER -